Amphastar Pharmaceuticals (AMPH) Acquisitions (2014 - 2016)

Amphastar Pharmaceuticals has reported Acquisitions for 3 years, with the latest figure at $3.4 million in Q4 2016.

• On a quarterly basis, Acquisitions fell 2.86% year-over-year to $3.4 million in Q4 2016; TTM through Dec 2016 was $11.7 million, a N/A change from a year earlier, with the FY2016 full-year figure at $12.5 million, up 256.03% from the prior year.
• Acquisitions was $3.4 million for Q4 2016 at Amphastar Pharmaceuticals, down from $4.8 million in the prior quarter.
• The five-year high for Acquisitions was $6.0 million in Q4 2014, with the low at $3.4 million in Q4 2016.
• Average Acquisitions over 3 years is $4.4 million, with a median of $4.1 million recorded in 2015.
• The sharpest annual moves came in 2015 and 2016: Acquisitions sank 41.67% in 2015, then retreated 2.86% in 2016.
• Over 3 years, Acquisitions stood at $6.0 million in 2014, then sank by 41.67% to $3.5 million in 2015, then fell by 2.86% to $3.4 million in 2016.
• The last three Acquisitions figures came in at $3.4 million (Q4 2016), $4.8 million (Q1 2016), and $3.5 million (Q4 2015), per Business Quant data.